Dr Robert Malone developed the platform technology that allowed mRNA to transfer into mammalian cells, by packaging it in a liposome with a positive charge. A liposome is a lipid sac that can carry drugs or other substances like mRNA into cells. This technology “induced a cellular immune response,” thus could be used as a vaccine.
Dr Malone’s patents contain “the first published research on mRNA vaccination” [1, 2, 3]
“In 1989, research was performed that gave rise to the groundbreaking patents on mRNA vaccination, all with a priority date of March 21, 1989. This is the same priority date as the Salk Patent application, showing that the two institutions were working together.”
Future lipid nanoparticle delivery systems are based on Dr Malone’s foundation technology.
The story of mRNA vaccine invention READ >>>